MorphoSys

MorphoSys AG, located in Martinsried/Munich, is one of the world's leading biotechnology companies focusing on fully human antibodies. With its unique technologies, MorphoSys is developing the next generation of antibodies, which can be used to treat diseases and for research and diagnostics purposes. Numerous partnerships have already been entered into with well-known companies from the pharmaceutical and biotechnology sectors, such as Boehringer Ingelheim, Daiichi Sankyo, Merck & Co, Novartis, Pfizer, and Roche.

Type
Public
HQ
Planegg, DE
Founded
1992

Key People at MorphoSys

Karin Eastham

Karin Eastham

Member & Supervisory Board
Walter Blättler

Walter Blättler

Member & Supervisory Board
Jens Holstein

Jens Holstein

Chief Financial Officer
Simon E. Moroney

Simon E. Moroney

Chief Executive Officer
Marc Cluzel

Marc Cluzel

Member & Supervisory Board
Daniel Camus

Daniel Camus

Member & Supervisory Board

MorphoSys Locations

Planegg, DE

MorphoSys Metrics

MorphoSys Summary

Founding Date

1992

Market capitalization

€1.07 B

Closing share price

€41.3

MorphoSys Market Value History

MorphoSys Online Presence

MorphoSys Company Life

You may also be interested in